Stockreport

How The BridgeBio Pharma (BBIO) Narrative Is Shifting With Attruby And Late Stage Pipeline [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF BridgeBio Pharma is back in focus after its fair value estimate was lifted from $89.79 to $100.05, an increase of about 11% that resets the conversation around upside a [Read more]